These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 17927286)
1. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
2. Spotlight on topiramate in epilepsy. Lyseng-Williamson KA; Yang LP CNS Drugs; 2008; 22(2):171-4. PubMed ID: 18193927 [TBL] [Abstract][Full Text] [Related]
3. Topiramate: a review of its use in childhood epilepsy. Ormrod D; McClellan K Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701 [TBL] [Abstract][Full Text] [Related]
4. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Langtry HD; Gillis JC; Davis R Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061 [TBL] [Abstract][Full Text] [Related]
11. Topiramate: a new antiepileptic drug. Markind JE Am J Health Syst Pharm; 1998 Mar; 55(6):554-62. PubMed ID: 9544331 [TBL] [Abstract][Full Text] [Related]
12. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Perucca E Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038 [TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. Shank RP; Maryanoff BE CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025 [TBL] [Abstract][Full Text] [Related]
14. Topiramate titration to response: analysis of individualized therapy study (TRAITS). Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538 [TBL] [Abstract][Full Text] [Related]
16. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial. Naritoku DK; Hulihan JF; Schwarzman LK; Kamin M; Olson WH Ann Pharmacother; 2005 Mar; 39(3):418-23. PubMed ID: 15701778 [TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952 [TBL] [Abstract][Full Text] [Related]
18. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly. Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344 [TBL] [Abstract][Full Text] [Related]
19. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Riva R; Albani F; Avoni P; Baruzzi A Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622 [TBL] [Abstract][Full Text] [Related]
20. Topiramate: a new antiepileptic drug for refractory epilepsy. Walker MC; Sander JW Seizure; 1996 Sep; 5(3):199-203. PubMed ID: 8902921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]